4//SEC Filing
Klausner Richard 4
Accession 0001209191-22-035825
CIK 0001806952other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:08 PM ET
Size
7.3 KB
Accession
0001209191-22-035825
Insider Transaction Report
Form 4
Klausner Richard
Director
Transactions
- Award
Option (right to buy)
2022-06-08+65,000→ 65,000 totalExercise: $5.31Exp: 2032-06-07→ Common Stock (65,000 underlying)
Holdings
- 1,000,000(indirect: By Trust)
Common Stock
- 2,967,834
Common Stock
Footnotes (2)
- [F1]Consists of 250,000 shares held by each of The Ariella Klausner Delaware Trust, The Eli Klausner Delaware Trust, The Isaac Klausner Delaware Trust, and The Olivia Klausner Delaware Trust. The Reporting Person is a trustee of each of the trusts and disclaims beneficial ownership of all shares held by the trusts except to any pecuniary interest therein.
- [F2]The option shares shall vest on the earlier of (a) the date of the next annual meeting of the stockholders that occurs following June 8, 2022 (or the date immediately prior to such date if the Reporting Person's service as a director ends at such annual meeting due to the Reporting Person's failure to be reelected or the Reporting Person not standing for re-election); or (b) the first anniversary of June 8, 2022, subject to the Reporting Person providing continuous service through such date.
Documents
Issuer
Lyell Immunopharma, Inc.
CIK 0001806952
Entity typeother
Related Parties
1- filerCIK 0001591178
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:08 PM ET
- Size
- 7.3 KB